{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:06:09Z","timestamp":1791828369122,"version":"4.3.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T00:00:00Z","timestamp":1714348800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012021","name":"Iran University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012021","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.heliyon.2024.e30521","type":"journal-article","created":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T05:24:55Z","timestamp":1714454695000},"page":"e30521","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Applications of magnetic resonance spectroscopy in diagnosis of neurodegenerative diseases: A systematic review"],"prefix":"10.1016","volume":"10","author":[{"given":"Fatemeh","family":"Abbaspour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niusha","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Amiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Cheraghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Ahadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9345-5706","authenticated-orcid":false,"given":"Zeinab","family":"Hormozi-Moghaddam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e30521_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/nbm.4301","article-title":"Complementarity of gluCEST and 1H\u2010MRS for the study of mouse models of Huntington's disease","volume":"33","author":"P\u00e9pin","year":"2020","journal-title":"NMR Biomed."},{"key":"10.1016\/j.heliyon.2024.e30521_bib2","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.3389\/fneur.2019.01173","article-title":"Quantifying the metabolic signature of multiple sclerosis by in vivo proton magnetic resonance spectroscopy: current challenges and future outlook in the translation from proton signal to diagnostic biomarker","volume":"10","author":"Swanberg","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.heliyon.2024.e30521_bib3","first-page":"7","article-title":"Imaging based magnetic resonance spectroscopy (MRS) localization for quantitative neurochemical analysis and cerebral metabolism studies","volume":"1","author":"Lee","year":"2017","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.heliyon.2024.e30521_bib4","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ejrnm.2016.10.001","article-title":"Role of DWI and MRS in diagnosis of Alzheimer's and pre-Alzheimer\u2019s disease","volume":"48","author":"Sultan","year":"2017","journal-title":"The Egyptian Journal of Radiology and Nuclear Medicine"},{"key":"10.1016\/j.heliyon.2024.e30521_bib5","article-title":"Radiological hints for differentiation of cerebellar multiple system atrophy from spinocerebellar ataxia","volume":"12","author":"Chen","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2024.e30521_bib6","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.neubiorev.2019.12.019","article-title":"Neurochemical profiles in hereditary ataxias: a meta-analysis of magnetic resonance spectroscopy studies","volume":"108","author":"Krahe","year":"2020","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.heliyon.2024.e30521_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-022-01329-4","article-title":"Cerebellar morphometric and spectroscopic biomarkers for Machado-Joseph Disease","volume":"10","author":"Miranda","year":"2022","journal-title":"Acta Neuropathologica Communications"},{"key":"10.1016\/j.heliyon.2024.e30521_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fnhum.2022.782579","article-title":"Cerebellar abnormalities on proton MR spectroscopy and imaging in patients with gluten ataxia: a pilot study","author":"Rawat","year":"2022","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.heliyon.2024.e30521_bib9","doi-asserted-by":"crossref","first-page":"e3880","DOI":"10.1002\/nbm.3880","article-title":"Expanded neurochemical profile in the early stage of Huntington disease using proton magnetic resonance spectroscopy","volume":"31","author":"Adanyeguh","year":"2018","journal-title":"NMR Biomed."},{"key":"10.1016\/j.heliyon.2024.e30521_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.838230","article-title":"Proton magnetic resonance spectroscopy for the early diagnosis of Parkinson disease in the substantia nigra and globus pallidus: a meta-analysis with trial sequential analysis","volume":"13","author":"Gu","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.heliyon.2024.e30521_bib11","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1590\/0004-282x20200094","article-title":"Differentiation of relapsing-remitting and secondary progressive multiple sclerosis: a magnetic resonance spectroscopy study based on machine learning","volume":"78","author":"Ek\u015f\u0130","year":"2020","journal-title":"Arquivos de Neuro-psiquiatria"},{"key":"10.1016\/j.heliyon.2024.e30521_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40673-019-0099-0","article-title":"Is 1 H-MR spectroscopy useful as a diagnostic aid in MSA-C?","volume":"6","author":"Kadodwala","year":"2019","journal-title":"Cerebellum & Ataxias"},{"key":"10.1016\/j.heliyon.2024.e30521_bib13","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.parkreldis.2018.12.008","article-title":"In vivo evidence for decreased scyllo-inositol levels in the supplementary motor area of patients with Progressive Supranuclear Palsy: a proton MR spectroscopy study","volume":"62","author":"Barbagallo","year":"2019","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.heliyon.2024.e30521_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1041610219001807","article-title":"Decreased glutamine and glutamate: an early biomarker of neurodegeneration","volume":"33","author":"Zeydan","year":"2021","journal-title":"Int. Psychogeriatr."},{"key":"10.1016\/j.heliyon.2024.e30521_bib15","author":"Jorgensen"},{"key":"10.1016\/j.heliyon.2024.e30521_bib16","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.3233\/JAD-170450","article-title":"Decreased N-acetyl aspartate\/myo-inositol ratio in the posterior cingulate cortex shown by magnetic resonance spectroscopy may be one of the risk markers of preclinical Alzheimer's disease: a 7-year follow-up study","volume":"60","author":"Waragai","year":"2017","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.heliyon.2024.e30521_bib17","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/acn3.530","article-title":"Magnetic resonance spectroscopy reveals abnormalities of glucose metabolism in the Alzheimer's brain","volume":"5","author":"Mullins","year":"2018","journal-title":"Annals of clinical and translational neurology"},{"key":"10.1016\/j.heliyon.2024.e30521_bib18","article-title":"Predicting conversion from mild cognitive impairment to Alzheimer's disease using brain 1H-MRS and volumetric changes: a two-year retrospective follow-up study","volume":"23","author":"Mitolo","year":"2019","journal-title":"Neuroimage: Clinica"},{"key":"10.1016\/j.heliyon.2024.e30521_bib19","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3233\/JAD-180861","article-title":"Distinctive neurochemistry in Alzheimer's disease via 7 T in vivo magnetic resonance spectroscopy","volume":"68","author":"Marja\u0144ska","year":"2019","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.heliyon.2024.e30521_bib20","doi-asserted-by":"crossref","first-page":"722","DOI":"10.3390\/brainsci12060722","article-title":"Lower posterior cingulate N-acetylaspartate to creatine level in early detection of biologically defined Alzheimer's disease","volume":"12","author":"Chen","year":"2022","journal-title":"Brain Sci."},{"key":"10.1016\/j.heliyon.2024.e30521_bib21","doi-asserted-by":"crossref","unstructured":"Murley A, Rouse M, Jones P, Ye R, Hezemans F, O'Callaghan C, et al. GABA and glutamate deficits from frontotemporal lobar degeneration are associated with disinhibition. Brain, 143; 3449\u20133462. https:\/\/doi.org\/10.1093\/brain\/awaa305. .","DOI":"10.1093\/brain\/awaa305"},{"key":"10.1016\/j.heliyon.2024.e30521_bib22","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1177\/0284185116683575","article-title":"Metabolic changes in normal-appearing white matter in patients with neuromyelitis optica and multiple sclerosis: a comparative magnetic resonance spectroscopy study","volume":"58","author":"Duan","year":"2017","journal-title":"Acta Radiol."},{"key":"10.1016\/j.heliyon.2024.e30521_bib23","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3390\/brainsci9050122","article-title":"Characterizing fatigue-related white matter changes in MS: a proton magnetic resonance spectroscopy study","volume":"9","author":"Yarraguntla","year":"2019","journal-title":"Brain Sci."},{"key":"10.1016\/j.heliyon.2024.e30521_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.792","article-title":"Detection and application of neurochemical profile by multiple regional 1H\u2010MRS in Parkinson's disease","volume":"7","author":"Guan","year":"2017","journal-title":"Brain and Behavior"},{"key":"10.1016\/j.heliyon.2024.e30521_bib25","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neulet.2017.08.050","article-title":"Evaluation of the Braak staging of brain pathology with 1H-MRS in patients with Parkinson's disease","volume":"660","author":"Cao","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.heliyon.2024.e30521_bib26","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3389\/fneur.2019.00777","article-title":"Altered neurometabolic profile in early Parkinson's disease: a study with short echo-time whole brain MR spectroscopic imaging","volume":"10","author":"Klietz","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.heliyon.2024.e30521_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12868-019-0522-8","article-title":"Comparative study of striatum GABA concentrations and magnetic resonance spectroscopic imaging in Parkinson's disease monkeys","volume":"20","author":"Huang","year":"2019","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.heliyon.2024.e30521_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-92532-1","article-title":"Multiparametric characterization of white matter alterations in early stage Huntington disease","volume":"11","author":"Adanyeguh","year":"2021","journal-title":"Sci. Rep."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024065526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024065526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T11:01:04Z","timestamp":1775732464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024065526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S2405844024065526"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e30521","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Applications of magnetic resonance spectroscopy in diagnosis of neurodegenerative diseases: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e30521","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e30521"}}